Journal article
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
Abstract
BACKGROUND: Survivors of acute myocardial infarction with frequent or repetitive ventricular premature depolarisations (VPDs) have higher mortality 1-2 years after the event than those without VPDs. Although there is no therapy of proven efficacy for such patients, previous studies of amiodarone have been encouraging. CAMIAT was a randomised double-blind placebo-controlled trial designed to assess the effect of amiodarone on the risk of …
Authors
Cairns JA; Connolly SJ; Roberts R; Gent M; Investigators FTCAMIAT
Journal
The Lancet, Vol. 349, No. 9053, pp. 675–682
Publisher
Elsevier
Publication Date
March 1997
DOI
10.1016/s0140-6736(96)08171-8
ISSN
0140-6736
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overAmiodaroneAnti-Arrhythmia AgentsArrhythmias, CardiacDeath, Sudden, CardiacDouble-Blind MethodElectrocardiography, AmbulatoryFemaleFollow-Up StudiesHumansMaleMiddle AgedMortalityMyocardial InfarctionPatient ComplianceRiskTreatment OutcomeVentricular FibrillationVentricular Premature Complexes